Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital

Coronary risk of patients with valvular heart disease: prospective validation of CT-Valve Score

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Time trends in the risk of atrial fibrillation and ischaemic stroke in patients with peripheral artery disease between 1997 and 2015

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Coronary risk stratification of patients with newly diagnosed heart failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Rasmus Bo Hasselbalch
  • Mia Marie Pries-Heje
  • Sarah Louise Kjølhede Holle
  • Thomas Engstrøm
  • Merete Heitmann
  • Frants Pedersen
  • Morten Schou
  • Hans Mickley
  • Hanne Elming
  • Rolf Steffensen
  • Lars Koeber
  • Kasper Iversen
View graph of relations

OBJECTIVE: To prospectively validate the CT-Valve score, a new risk score designed to identify patients with valvular heart disease at a low risk of coronary artery disease (CAD) who could benefit from multislice CT (MSCT) first instead of coronary angiography (CAG).

METHODS: This was a prospective cohort study of patients referred for valve surgery in the Capital Region of Denmark and Odense University Hospital from the 1 February 2015 to the 1 February 2017. MSCT was implemented for patients with a CT-Valve score ≤7 at the referring physician's discretion. Patients with a history of CAD or chronic kidney disease were excluded. The primary outcome was the proportion of patients needing reevaluation with CAG after MSCT and risk of CAD among the patients determined to be low to intermediate risk.

RESULTS: In total, 1149 patients were included. The median score was 9 (IQR 3) and 339 (30%) had a score ≤7. MSCT was used for 117 patients. Of these 29 (25%) were reevaluated and 9 (7.7%) had CAD. Of the 222 patients with a score ≤7 that did not receive an MSCT, 14 (6%) had significant CAD. The estimated total cost of evaluation among patients with a score ≤7 before implementation was €132 093 compared with €79 073 after, a 40% reduction. Similarly, estimated total radiation before and after was 608 mSv and 362 mSv, a 41% reduction. Follow-up at a median of 32 months (18-48) showed no ischaemic events for patients receiving only MSCT.

CONCLUSION: The CT-Valve score is a valid method for determining risk of CAD among patients with valvular heart disease. Using a score ≤7 as a cut-off for the use of MSCT is safe and cost-effective.

Original languageEnglish
Article numbere001380
JournalOpen Heart
Issue number2
Publication statusPublished - 5 Oct 2020

    Research areas

  • coronary artery disease, risk stratification, valvular disease

ID: 61009662